@unleashed.trt's subcutaneous TRT claims, fact-checked

What did @unleashed.trt actually say?

The creator was responding to a question about injecting "test-sib-250" (testosterone cypionate 250mg/mL) subcutaneously. Their core argument: yes, you can do it, but the real question is whether the volume and individual tolerance make it practical. They put a rough ceiling of "up to 0.5 ml" for subcutaneous (sub-Q) injections, said absorption is comparable or possibly steadier than intramuscular (IM), and acknowledged that some men get persistent lumps and skin irritation no matter what technique they use. For those patients, they suggested IM might be more appropriate.

That is, broadly speaking, a reasonable clinical framing. It is not sensationalism. It is not a promise of superior outcomes. It is a dose-volume discussion dressed up for TikTok, and it holds up better than most TRT content on the platform.

Does the science back this up?

Mostly, yes. The 0.5 mL volume threshold is not pulled from thin air, and the claim about comparable absorption is supported by real data.

A 2021 study by Spratt et al. in The Journal of Clinical Endocrinology and Metabolism found that subcutaneous testosterone cypionate produced testosterone levels comparable to IM administration, with some evidence of a smoother pharmacokinetic curve, meaning fewer peak-to-trough swings. That matches the creator's claim of "possibly even more steadily" absorbed.

On volume tolerance, the general clinical guidance from injection technique literature (including Nicoll et al., 2012, Practical Diabetes) suggests subcutaneous depots are poorly suited to volumes above 1 mL, with 0.5 mL being a commonly cited comfortable upper limit for most patients. The creator's threshold is consistent with that.

The lumps and skin irritation issue is also real. Local reactions, including nodules, induration, and erythema, are documented adverse effects of subcutaneous oil-based injections and are more common with higher volumes or poor technique.

What did they get right, and what's missing?

They got the volume threshold right. They got the absorption comparison right. They were honest that sub-Q is not universally tolerated, which is more nuance than most creators offer. Credit where it is due.

What is missing: no mention of injection site rotation, which matters a lot for avoiding chronic subcutaneous nodules. No mention of concentration as a variable. A 250 mg/mL formulation injected sub-Q is a different conversation than 100 mg/mL, because higher concentration oils can cause more local irritation regardless of volume. If someone is on a high-concentration compounded testosterone, "0.5 mL is fine" is not the complete picture.

There is also a gap around patient selection. Men with higher body fat may actually tolerate sub-Q injections better because there is more subcutaneous tissue to distribute the depot. Men who are lean may hit that 0.5 mL limit faster. That context would have made this more clinically complete.

What should you actually know?

Subcutaneous testosterone injections are a legitimate, evidence-backed administration route. They are not experimental. The FDA-approved testosterone product Xyosted is specifically formulated for subcutaneous injection, which tells you the regulatory community has accepted the route.

However, a few things matter that this video did not fully address. First, oil viscosity and concentration affect tolerability. Not all testosterone formulations behave the same sub-Q. Second, injection site rotation is not optional if you want to avoid chronic nodule formation. Abdomen, lateral thigh, and flank are commonly used sites. Rotating between them reduces tissue buildup. Third, if you are getting persistent lumps, that is a signal worth discussing with your prescribing clinician, not just a technique problem to troubleshoot alone. Lumps are usually benign oil granulomas, but they should be evaluated.

Finally: do not self-adjust your injection route without talking to whoever manages your prescription. Switching from IM to sub-Q can change your absorption profile enough to affect your lab results, which then affects how your clinician interprets your levels and adjusts your protocol.